1. Home
  2. KRYS vs IT Comparison

KRYS vs IT Comparison

Compare KRYS & IT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Krystal Biotech Inc.

KRYS

Krystal Biotech Inc.

HOLD

Current Price

$344.64

Market Cap

10.1B

Sector

Health Care

ML Signal

HOLD

Logo Gartner Inc.

IT

Gartner Inc.

HOLD

Current Price

$151.00

Market Cap

9.8B

ML Signal

HOLD

Company Overview

Basic Information
Metric
KRYS
IT
Founded
2015
1979
Country
United States
United States
Employees
295
40
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Other Consumer Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
10.1B
9.8B
IPO Year
2017
2010

Fundamental Metrics

Financial Performance
Metric
KRYS
IT
Price
$344.64
$151.00
Analyst Decision
Strong Buy
Hold
Analyst Count
11
9
Target Price
$297.60
$189.25
AVG Volume (30 Days)
548.4K
1.2M
Earning Date
05-04-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
128.00
N/A
EPS
1.83
3.18
Revenue
$389,130,000.00
$2,021,441,000.00
Revenue This Year
$38.74
$3.52
Revenue Next Year
$32.53
$5.08
P/E Ratio
$199.26
$47.80
Revenue Growth
33.94
13.30
52 Week Low
$130.50
$124.25
52 Week High
$382.54
$337.29

Technical Indicators

Market Signals
Indicator
KRYS
IT
Relative Strength Index (RSI) 48.69 55.77
Support Level $246.17 $142.37
Resistance Level $382.33 $162.80
Average True Range (ATR) 18.24 6.97
MACD -0.46 2.60
Stochastic Oscillator 53.10 58.28

Price Performance

Historical Comparison
KRYS
IT

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is an integrated, commercial-stage biotechnology company focused on the discovery, development, manufacturing, and commercialization of genetic medicines to treat diseases with high unmet medical needs. The company uses its patented HSV-1-based gene therapy platform to create vectors that deliver therapeutic transgenes to target cells. It possesses exclusive rights to develop, manufacture, and commercialize VYJUVEK internationally. The company operates as one operating segment focused on pharmaceutical products and manufactures, markets, and sells VYJUVEK in the United States and markets and sells VYJUVEK in the European Union, and Japan.

About IT Gartner Inc.

Gartner Inc delivers actionable, objective business and technology insights that drive smarter decisions and stronger performance on an organization's mission-critical priorities. It delivers its products and services globally through three reportable segments - Business and Technology Insights, Conferences and Consulting. Insights equips executives and their teams from every Majority function, geography, industry and sector with actionable, objective insights, guidance and tools. Conferences provides executives and teams across an organization the opportunity to learn, share and network. and Consulting serves senior executives technology-driven strategic initiatives leveraging the power of Gartner's actionable, objective insight. The Majority revenue is derived from the Insights segment.

Share on Social Networks: